Discrepancies in breast cancer screening and hypothesis of artificial intelligence support

Abstract In Italy,the National Breast Screening Programme offers mammography as the 1st level examination, blindly assessed by two radiologists.In the context of continuous quality control,discrepancies in the assessment of mammograms between the 1st and 2nd reader have been studied,focusing on the most significant ones.The aims of the present study are:to evaluate the outcome of women sent to the 2nd level of review;to evaluate the possibility of using artificial intelligence (AI) software to assist radiologists in case of discrepancies. In the Local Health Authority Roma2,radiologists use a standardised classification that rates radiographs on a five-level scale from R1 to R5:R1=no abnormalities,R2=benign findings,R3=equivocal findings,R4=suspected cancer,R5=strongly suspected cancer.Data were extracted from the mammograms performed in 2023 that showed discrepancies (R1/R2 vs. R4/R5).2nd level mammography≥R4 and 2nd level histology≥B4 were considered positive. For the second aim,”IA Lunit INSIGHT” software was used to create specific target groups using the following cut-offs:G1<10%, G2 11-29%; G3 30-59%; G4 60-85%; G5 86-100%(groups ≥G3 were considered positive). Of the 36,339 mammograms,524(1.5%) were discordant:347(66.2%) were considered suspicious by the second radiologist.49(9.4%) were confirmed positive by Level II mammography and 23(4.4%) reported histology≥B4. The AI red a random sample of 247 mammograms and classified 34 women as positive (1 G5, 6 G4, 9 G3), of whom 11 (4.5%) were confirmed positive by Level II mammography and 6 (2.4%) were histologically positive. Of the negative women, 2 had histology≥B4. Discrepancies may be one of the factors leading to inappropriate referral to second level investigation. In such cases, the use of AI may improve the appropriateness of further investigation, although this hypothesis needs to be tested in larger numbers, with additional comparisons with experienced radiologists and consideration of retraining. Key messages • Continuous monitoring in cancer screening programs are vital to assure a sustainability of the process. • Artificial Intelligence software are promising in aiding health care professionals in case of discrepancies.

Authors

Institutions

Publication Details

Journal
European Journal of Public Health
Published
2024-10-28
DOI
https://doi.org/10.1093/eurpub/ckae144.1196
Primary Topic
Radiomics and Machine Learning in Medical Imaging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discrepancies in breast cancer screening and hypothesis of artificial intelligence support

GENNARO CERONE, Maria Teresa Riccardi, Virginia Rosca, Emanuela Rossi et al.
European Journal of Public Health
Radiomics and Machine Learning in Medical Imaging
article

Discrepancies in breast cancer screening and hypothesis of artificial intelligence support

GENNARO CERONE, Maria Teresa Riccardi, Virginia Rosca, Emanuela Rossi, Antonella Testa, Francesca Maria Forestiero, Massimo Oddone Trinito, T Rudniki
article en

Abstract

Abstract In Italy,the National Breast Screening Programme offers mammography as the 1st level examination, blindly assessed by two radiologists.In the context of continuous quality control,discrepancies in the assessment of mammograms between the 1st and 2nd reader have been studied,focusing on the most significant ones.The aims of the present study are:to evaluate the outcome of women sent to the 2nd level of review;to evaluate the possibility of using artificial intelligence (AI) software to assist radiologists in case of discrepancies. In the Local Health Authority Roma2,radiologists use a standardised classification that rates radiographs on a five-level scale from R1 to R5:R1=no abnormalities,R2=benign findings,R3=equivocal findings,R4=suspected cancer,R5=strongly suspected cancer.Data were extracted from the mammograms performed in 2023 that showed discrepancies (R1/R2 vs. R4/R5).2nd level mammography≥R4 and 2nd level histology≥B4 were considered positive. For the second aim,”IA Lunit INSIGHT” software was used to create specific target groups using the following cut-offs:G1<10%, G2 11-29%; G3 30-59%; G4 60-85%; G5 86-100%(groups ≥G3 were considered positive). Of the 36,339 mammograms,524(1.5%) were discordant:347(66.2%) were considered suspicious by the second radiologist.49(9.4%) were confirmed positive by Level II mammography and 23(4.4%) reported histology≥B4. The AI red a random sample of 247 mammograms and classified 34 women as positive (1 G5, 6 G4, 9 G3), of whom 11 (4.5%) were confirmed positive by Level II mammography and 6 (2.4%) were histologically positive. Of the negative women, 2 had histology≥B4. Discrepancies may be one of the factors leading to inappropriate referral to second level investigation. In such cases, the use of AI may improve the appropriateness of further investigation, although this hypothesis needs to be tested in larger numbers, with additional comparisons with experienced radiologists and consideration of retraining. Key messages • Continuous monitoring in cancer screening programs are vital to assure a sustainability of the process. • Artificial Intelligence software are promising in aiding health care professionals in case of discrepancies.

European Journal of Public HealthVol. 34(Supplement_3)
University of Rome Tor Vergata (IT), Regional Health (US), Sapienza University of Rome (IT)
Good health and well-being
Openalex Percentile: Top 68%
Radiomics and Machine Learning in Medical Imaging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.